Candidate Profiling & Selection process – developing in vitro and in vivo pharmacology plans based on best practice animal models, protocol support for outsourced animal studies. Plan translational studies that provide testable disease hypothesis from the lab to clinic patient support: Efficacy vs Tox analysis. BusStim will deliver a clinical candidate nomination document which will contain pharmacological, chemical and DMPK assessment of the compound selected for development.
BusStim will evaluate whether the compound is:
Business Stimulant Consultants, LLC
3240 Henry Hudson Parkway
Riverdale, NY 10463